In the BCR-ABL+ ALL cell line, BV173, DEX and DAS enhance pro-apoptotic BIM expression and, at the same time, reduce anti-apoptotic BCLXL and MCL1 protein levels (Figure S3a). The gene discussed is BCL2L1; the disease is acute lymphoblastic leukemia.